West Pharmaceutical Services Inc.
Michel Lagarde (President and CEO) reports WST insider transactions
About this filing
West Pharmaceutical Services Inc. (WST) filed Form 4 (insider transaction) with the SEC on Sep 10, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Michel Lagarde · President and CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | A · grantStock Option (Right to Buy)Footnotes F1 | +13,879 | $0.00 | $0.00 | 13,879 | Direct |
| Sep 8, 2026 | A · grantStock Option (Right to Buy)Footnotes F1 | +11,081 | $0.00 | $0.00 | 11,081 | Direct |
| Sep 8, 2026 | A · grantStock Option (Right to Buy)Footnotes F2 | +12,088 | $0.00 | $0.00 | 12,088 | Direct |
| Sep 8, 2026 | A · grantRst. Stock UnitFootnotes F3, F1 | +6,200 | $0.00 | $0.00 | 6,200 | Direct |
| Sep 8, 2026 | A · grantRst. Stock UnitFootnotes F3, F1 | +4,950 | $0.00 | $0.00 | 4,950 | Direct |
| Sep 8, 2026 | A · grantRst. Stock UnitFootnotes F3, F2 | +3,600 | $0.00 | $0.00 | 3,600 | Direct |
Footnotes
- F1 This award vests in four equal annual installments beginning on September 8, 2027.
- F2 This award cliff vests on September 8, 2031.
- F3 Each restricted stock unit represents a contingent right to receive one share of WST common stock.
More WST filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.